Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00737-023-01322-3 | DOI Listing |
Subst Abuse Treat Prev Policy
January 2025
Tobacco Control Unit, Cancer Control and Prevention Program, Institut Català d'OncologiaL'Hospitalet de Llobregat, Barcelona, Spain.
Introduction: Global demand for the treatment of cannabis use disorder has increased significantly, prompting a need to understand effective strategies for addressing concurrent cannabis and tobacco use. This study focuses on clinicians' experiences and perceptions in delivering tobacco cessation services to people who use cannabis.
Methods: Fifteen participants (12 females, 3 males) participated in three homogenous focus groups, including two groups with extensive experience in providing tobacco cessation among the substance use population in Catalonia, Spain, and one group of clinicians without such experience.
JMIR Ment Health
January 2025
West Region, Institute of Mental Health, Singapore, Singapore.
Background: Previous studies have found that psychotic disorders are among the most stigmatized mental disorders. Of note, virtual reality (VR) interventions have been associated with improvements in attitudes and empathy and reduced stigma toward individuals with psychotic disorders, especially among undergraduates, but this has not been examined among mental health care professionals.
Objective: We aimed to evaluate the effectiveness of a newly developed VR intervention for mental health care professionals to improve attitudes and empathy and reduce stigma toward people with psychotic disorders.
Int J STD AIDS
January 2025
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Background: This study investigates the use of patient portals for disclosing sexually transmitted infection (STI) test result histories to sexual partners among men who have sex with men (MSM) in the United States.
Methods: Using data from the 2022-2023 American Men's Internet Survey, this cross-sectional analysis examined demographic, behavioral, and healthcare-related factors associated with MSM's utilization of patient portals for sharing STI test results. Participants ( = 2601) were surveyed on portal use, STI testing frequency, and partner disclosure practices.
Int Clin Psychopharmacol
January 2025
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa.
Schizophrenia is a serious psychiatric condition requiring continuous treatment with antipsychotic medications available in different formulations, including oral antipsychotics (OAPs) and long-acting injectables (LAIs). This narrative review aims to comprehensively outline the advantages and disadvantages of OAPs and LAIs to support clinicians in choosing different formulations based on the presentation of clinical symptoms. An electronic search of the PubMed database was performed in June 2024, and additional articles were retrieved from the references or personal knowledge of the authors.
View Article and Find Full Text PDFHealth Promot Int
January 2025
Center for Mental Health and Community Wellbeing, Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Carlton, Victoria 3053, Australia.
Public disclosures of mental health problems on social media represent a potentially powerful informal avenue for increasing mental health literacy and reducing public stigma in relation to people with mental health problems. We investigated whether the audience reported any reduction in their own stigma toward people with mental health problems after exposure to disclosures. We also examined whether self-reported stigma reduction was associated with the characteristics of audience members, the disclosers and the disclosure messages.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!